Evidence map›Paper›PMID 38399409›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Unique Effects of (R)-Ketamine Compared to (S)-Ketamine on EEG Theta Power in Rats.

Dóra Pothorszki, Szabolcs Koncz, Dóra Török, Noémi Papp, György Bagdy

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. (International journal of molecular sciences · 2024
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dóra PothorszkiDepartment of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.
Szabolcs KonczDepartment of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.ORCID 0000-0002-9465-945X
Dóra TörökDepartment of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.ORCID 0000-0001-9213-4345
Noémi PappDepartment of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.
György BagdyDepartment of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, 1089 Budapest, Hungary.ORCID 0000-0001-8141-3410
Semmelweis University · HU

Funding

Hungarian Academy of Sciences Hungarian Brain Research Program 3.0 (NAP2022-I-4/2022)Hungarian Academy of Sciences Hungarian Brain Research Program (grant: 2017-1.2.1-NKP-2017-00002)Ministry for Culture and Innovation ÚNKP-22-4-I-SE-26 New National Excellence ProgramMinistry for Culture and Innovation ÚNKP-23-3-I-SE-43 New National Excellence ProgramMinistry for Innovation and Technology in Hungary Thematic Excellence Program (2020-4.1.1.-TKP2020, TKP2021-EGA-25)Richter Gedeon Talentum Foundation established by Richter Gedeon Plc. Richter Gedeon PhD Scholarship
6 · The paper itself

Abstract

Differences in the pharmacological effects of (S)-ketamine and (R)-ketamine are at the focus of research. Clinical data and our rat studies confirmed the antidepressant effect of (S)- but not (R)-ketamine, with similar differences in quantitative electroencephalogram (EEG) and sleep effects. In contrast, studies mainly on mice showed some stronger, preferable effects of (R)-ketamine. EEG theta (5-9 Hz) rhythm originates from the hippocampus, and its power is associated with cognitive functions, attention, and decreased anxiety. To find a brain parameter that is not associated with the antidepressant effect of drugs and may confirm potent in vivo effects of (R)-ketamine in rats, theta EEG power-inducing effects of the two enantiomers were measured and compared for 23 h. EEG-equipped Wistar rats were treated with (R)-ketamine (7.5, 15, 30 mg/kg i.p.), (S)-ketamine (7.5 and 15 mg/kg i.p.), or vehicle at the beginning of the passive phase. Frontoparietal EEG, electromyogram, and motor activity were recorded. (R)-ketamine but not (S)-ketamine dose-dependently increased EEG theta power during wakefulness and rapid eye movement (REM) sleep for 23 h. These results suggest that (R)-ketamine has an effect on a hippocampal function that was not affected by (S)-ketamine and may be associated with neural plasticity and memory encoding.

Indexed as

antidepressantarketaminecognitionelectroencephalographyesketaminememoryneuroplasticityquantitative EEGREM sleeptheta rhythm

Identifiers

PMID38399409
PMCPMC10893209
OpenAlexW4391450406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.